Home

Verona Pharma plc - American Depositary Shares (VRNA)

84.34
-1.20 (-1.40%)
NASDAQ · Last Trade: Jun 8th, 3:45 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.
Via MarketBeat · October 4, 2022
Verona Pharma (NASDAQ: VRNA) Reports its Phase 3 ENHANCE-2 Trial of Ensifentrine Met Primary Endpoint in Treating COPD
Verona Pharma plc (NASDAQ: VRNA) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and
Via Spotlight Growth · August 9, 2022
The Healthcare Companies Fighting the World’s Biggest Killers
Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are constantly innovating to try to combat these illnesses, pushing hard to find breakthrough cures and quality of life improvements. In […]
Via FinancialNewsMedia · July 13, 2022